Showing results (111-120 of 222) with videos related to

Sort By:
Pageof 23
Hepatology (Baltimore, Md.)|March 5, 2004
Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis BMonika van Zonneveld, Pieter Honkoop, Bettina E Hansen, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 16, 2019
The impact of imaging on the surgical management of biliary cystadenomas and cystadenocarcinomas; a systematic reviewAnne J Klompenhouwer, David W G Ten Cate, Francois E J A Willemssen, et al.
Hepatology International|March 23, 2013
Recently introduced biomarkers for screening of hepatocellular carcinoma: a systematic review and meta-analysisCaroline D M Witjes, Susanna M van Aalten, Ewout W Steyerberg, et al.
European Journal of Internal Medicine|December 3, 2022
Patients treated with rituximab are poorly screened for hepatitis B infection: Data from a low-incidence countrySylvia M Brakenhoff, Roos Hoekstra, Pieter Honkoop, et al.
United European Gastroenterology Journal|August 18, 2017
Nodular regenerative hyperplasia rarely leads to liver transplantation: A 20-year cohort study in all Dutch liver transplant unitsBerrie Meijer, Melek Simsek, Hans Blokzijl, et al.
World Journal of Gastroenterology|April 28, 2015
Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudineScott Bowden, Stephen Locarnini, Ting-Tsung Chang, et al.
Digestive Surgery|April 4, 2013
Increased alpha-fetoprotein serum level is predictive for survival and recurrence of hepatocellular carcinoma in non-cirrhotic liversCaroline D M Witjes, Wojciech G Polak, Cornelis Verhoef, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 10, 2012
Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survivalCaroline D M Witjes, Henrike E Karim-Kos, Otto Visser, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 12, 2013
Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patientsSuzan D Pas, Roel H R A Streefkerk, Mark Pronk, et al.
Pageof 23